Table 1 Demographic and clinical co-variates.

From: Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission

 

Total N = 1859

Non-cancer N = 1794 (97)

Cancer N = 65 (3)

P-value

Co-variates

Age, median (IQR), years

59 (45, 68)

59 (45, 68)

63 (54, 70)

0.054

Age

   

0.194

  <65 years

1199 (65)

1162 (65)

37

 

  ≥65 years

660 (36)

632 (35)

28

 

Male

934 (50)

903 (50)

31

0.706

Smoking history

111 (6)

105 (6)

6

0.019

  Former smoker

66 (4)

60 (3)

6

 

  Current smoker

45 (2)

45 (3)

0

 

Exposure history

   

0.036

  Huanan Seafood Market

4 (0.2)

3 (0.2)

1

 

  Close contact with infected persons

78 (4)

77 (4)

1

 

Co-morbidity

  ASCVD

268 (14)

259 (14)

9

>0.999

  Arterial hypertension

579 (31)

559 (31)

20

>0.999

  Diabetes mellitus

262 (14)

250 (14)

12

0.303

  COPD

61 (3)

60 (3)

1

0.722

  Chronic kidney disease

45 (2)

44 (3)

1

>0.999

  Gastro-intestinal disease

98 (5)

93 (5)

5

0.388

Signs and symptoms

  Fevera

1448 (78)

1399 (78)

49

0.608

  Temperature (°C)b

36.6 (36.4, 37.0)

36.6 (36.4, 37.1)

36.6 (36.5, 36.9)

0.464

  Shortness of breath

716 (39)

685 (38)

31

0.123

  Dry cough

619 (43)

597 (43)

22

0.294

  Wet cough

715 (39)

684 (38)

31

0.12

  Fatigue

695 (37)

670 (37)

25

0.858

  Nausea and/or vomiting

124 (9)

116 (8)

8

0.21

  Diarrhea

243 (13)

234 (13)

9

0.852

  Chills

281 (19)

274 (20)

7

0.137

  Rhinorrhea

33 (2)

32 (2)

1

>0.999

  Myalgia

315 (17)

305 (17)

10

0.867

  Headache

107 (6)

105 (6)

2

0.583

Radiological co-variates

  Bilateral pneumonia

1570 (88)

1515 (88)

55

0.693

  Consolidation

326 (19)

314 (18)

12

0.754

  Ground-glass opacity

1331 (75)

1287 (75)

44

0.6

  Patchy shadows

736 (42)

700 (41)

36

0.005

COVID-19 severity

0.003

  Mild

34 (2)

33 (2)

1

 

  Moderate

1170 (63)

1141 (64)

29

 

  Severe

453 (24)

433 (24)

20

 

  Critical

202 (11)

187 (10)

15

 
  1. Data are median (IQR) or n (%).
  2. ASCVD cardio- and cerebro-vascular disease, COPD chronic obstructive pulmonary disease
  3. a≥1 temperature ≥ 37.3 °C from onset of symptoms to admission.
  4. bAdmission temperature.